The influence of leukocytospermia on the outcomes of assisted reproductive technology

dc.contributor.authorCavagna, Mario
dc.contributor.authorOliveira, Joao Batista A. [UNESP]
dc.contributor.authorPetersen, Claudia G. [UNESP]
dc.contributor.authorMauri, Ana L.
dc.contributor.authorSilva, Liliane F. I. [UNESP]
dc.contributor.authorMassaro, Fabiana C.
dc.contributor.authorBaruffi, Ricardo L. R.
dc.contributor.authorFranco, Jose G. [UNESP]
dc.contributor.institutionCtr Human Reprod Prof Franco Jr
dc.contributor.institutionHosp Perola Byington
dc.contributor.institutionPaulista Ctr Diag Res & Training
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:35:39Z
dc.date.available2014-05-20T13:35:39Z
dc.date.issued2012-06-15
dc.description.abstractBackground: It is not well established whether the increased number of leukocytes in the seminal fluid impairs the outcomes of assisted reproductive technology (ART). This investigation analysed the outcomes of the intracytoplasmic sperm injection (ICSI) and intracytoplasmic morphologically selected sperm injection (IMSI) cycles in couples in which the male partner exhibited leukocytospermia.Methods: A total of 100 cycles in 100 couples were included in this study. For the ICSI or IMSI procedures, the patients were divided into two groups according to the presence or absence of leukocytospermia and then matched by (female) age:- ICSI: Group I (n = 25): Leukocytospermia - semen samples with a leukocyte count of greater than or equal to 1 x 10(6)/mL; and Group II (n = 25): Non-leukocytospermia - semen samples with a leukocyte count < 1 x 10(6)/mL.- IMSI: Group I (n = 25): Leukocytospermia; and Group II (n = 25): Non-leukocytospermia.The endpoints included the rates of fertilisation, implantation, clinical pregnancy, miscarriage, ongoing pregnancy and live birth. Student's t-tests, Mann-Whitney tests and Chi-square tests were performed, and P < 0.05 was considered significant.Results: The data from the ICSI groups showed that leukocytospermia did not have a negative influence on the rates of fertilisation (Group I: 57.9+/-30.2%, Group II: 61.9+/-27.7%; P = 0.74), implantation (Group I: 12.3%; Group II: 13.5%; P = 0.93), clinical pregnancy (Group I: 24%; Group II: 24%; P = 1.0), miscarriage ( Group I: 0, Group II: 0), ongoing pregnancy (Group I: 24%; Group II: 24%; P = 1.0), or live births (Group I: 24%; Group II: 24%; P = 1.0). Similarly, the data from the IMSI groups also showed that the leukocytospermia did not have a negative influence on the rates of fertilisation (Group I: 67.6+/-24.6%, Group II: 59.5+/-28.1%; P = 0.36), implantation (Group I: 17.5%; Group II: 16.7%; P = 0.90), clinical pregnancy (Group I: 28%; Group II: 24%; P = 1.0), miscarriage (Group I: 14.3%; Group II: 0; P = 0.33), ongoing pregnancy (Group I: 24%; Group II: 24%; P = 1.0), or live births (Group I: 24%, 6/25; Group II: 24%, 6/25; P = 1.0).Conclusions: The results indicate that the leukocytospermia may not have a negative effect on the outcomes of ICSI or IMSI cycles. Nevertheless, it seems that it is necessary to more precisely determine the effects, if any, of seminal leukocytes on fertilisation and implantation processes. Such efforts will help to establish a more reliable leukocyte threshold, which could eventually demonstrate whether there is a negative influence on the ART procedures.en
dc.description.affiliationCtr Human Reprod Prof Franco Jr, Ribeirao Preto, Brazil
dc.description.affiliationHosp Perola Byington, Womens Hlth Reference Ctr, São Paulo, Brazil
dc.description.affiliationPaulista Ctr Diag Res & Training, Ribeirao Preto, Brazil
dc.description.affiliationSão Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, Brazil
dc.description.affiliationUnespSão Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, Brazil
dc.format.extent10
dc.identifierhttp://dx.doi.org/10.1186/1477-7827-10-44
dc.identifier.citationReproductive Biology and Endocrinology. London: Biomed Central Ltd., v. 10, p. 10, 2012.
dc.identifier.doi10.1186/1477-7827-10-44
dc.identifier.fileWOS000308910500001.pdf
dc.identifier.issn1477-7827
dc.identifier.urihttp://hdl.handle.net/11449/12275
dc.identifier.wosWOS:000308910500001
dc.language.isoeng
dc.publisherBiomed Central Ltd.
dc.relation.ispartofReproductive Biology and Endocrinology
dc.relation.ispartofjcr2.852
dc.relation.ispartofsjr1,203
dc.rights.accessRightsAcesso aberto
dc.sourceWeb of Science
dc.subjectLeukocytospermiaen
dc.subjectICSIen
dc.subjectIMSIen
dc.subjectReactive oxygen speciesen
dc.subjectDNA damageen
dc.titleThe influence of leukocytospermia on the outcomes of assisted reproductive technologyen
dc.typeArtigo
dcterms.licensehttp://www.biomedcentral.com/about/license
dcterms.rightsHolderBiomed Central Ltd.
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt
unesp.departmentGinecologia e Obstetrícia - FMBpt

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
WOS000308910500001.pdf
Tamanho:
216.46 KB
Formato:
Adobe Portable Document Format

Licença do Pacote

Agora exibindo 1 - 2 de 2
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: